C12orf40 Inhibitors
Chemical inhibitors of C12orf40 encompass a wide range of compounds that target various signaling pathways to inhibit the functional activity of this protein. Staurosporine, a potent kinase inhibitor, can reduce the phosphorylation levels of proteins within C12orf40's signaling pathways, leading to its functional inhibition. Similarly, Genistein, by targeting tyrosine kinases, can prevent phosphorylation events essential for C12orf40's activity. LY294002 and Wortmannin function as PI3K inhibitors, which can interrupt the PI3K/AKT pathway, a potential influencer of C12orf40's activity. This interruption can restrain the functional activity of C12orf40 by halting necessary activation steps within this pathway.
MEK inhibitors such as PD98059 and U0126 can impair the MAPK/ERK pathway, which, if utilized by C12orf40 for its signaling, can lead to decreased activity of the protein. This is accomplished by preventing the upstream activation of ERK, a kinase that could be critical for C12orf40's function. Furthermore, Rapamycin, by specifically inhibiting the mTOR pathway, can affect protein synthesis and cell growth processes that may involve C12orf40. Inhibitors of the JNK signaling such as SP600125 and p38 MAP kinase inhibitors like SB203580 can prevent the phosphorylation of transcription factors and other downstream targets that might be necessary for C12orf40's functional activity. Lastly, Dasatinib and PP2, as tyrosine kinase inhibitors, can obstruct signaling pathways that activate C12orf40, while PD173074, by inhibiting FGFR, can interfere with the downstream signaling that may be critical for C12orf40's activity. Each of these chemical inhibitors can exert a distinct impact on the functional activity of C12orf40 by modulating different signaling pathways and kinases involved in its regulation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases, including those kinases involved in the activation or regulation of C12orf40. By inhibiting these kinases, staurosporine can lead to a decrease in the phosphorylation states of proteins within the signaling pathways that C12orf40 is a part of, thereby inhibiting the functional activity of C12orf40. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that can inhibit the phosphorylation of proteins within the signal transduction pathways that C12orf40 operates in. This inhibition can reduce the functional activity of C12orf40 by preventing the necessary phosphorylation events required for its proper function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a specific inhibitor of MEK, which acts upstream of MAP kinases. Inhibition of MEK can lead to reduced MAP kinase activity, which can in turn inhibit the functional activity of C12orf40 if it relies on MAP kinase signaling for its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a phosphatidylinositol 3-kinase (PI3K) inhibitor. By inhibiting PI3K, LY294002 can prevent the activation of the PI3K/AKT pathway, which can inhibit the functional activity of C12orf40 if the protein's function is dependent on this pathway for signal transduction. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which is upstream of ERK in the MAPK pathway. Inhibition of MEK1/2 by U0126 can lead to reduced ERK activity. If C12orf40 relies on ERK signaling for its activity, this inhibition can reduce the functional activity of C12orf40. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin specifically inhibits the mTOR (mammalian target of rapamycin) pathway. The inhibition of mTOR can lead to reduced protein synthesis and cell proliferation, which can inhibit the functional activity of C12orf40 if it is involved in processes regulated by mTOR. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which is a component of the MAPK pathway. By inhibiting JNK, SP600125 can prevent the phosphorylation and activation of transcription factors that may be necessary for the functional activity of C12orf40. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAP kinase. Inhibition of p38 MAP kinase by SB203580 can interfere with the signaling pathways that involve this kinase, potentially leading to an inhibition of the functional activity of C12orf40 if it is dependent on p38 MAPK signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent and irreversible inhibitor of PI3K. By inhibiting PI3K, wortmannin can disrupt the PI3K/AKT pathway, potentially leading to an inhibition of the functional activity of C12orf40 if the protein's function is associated with this pathway. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a broad-spectrum tyrosine kinase inhibitor that can inhibit the Src family of kinases as well as other kinases. Inhibition of these kinases by dasatinib can prevent the activation of downstream signaling pathways that may be required for the functional activity of C12orf40. | ||||||